News

How to catch and kill a coronavirus
on a doorknob

John Arnst
May 27, 2020

More than two months after the World Health Organization declared the outbreak of the new coronavirus a global pandemic, we lather and scrub our hands — singing Happy Birthday, twice, or maybe the chorus to Mr. Brightside — to wash away the possibility that we’ll bring the virus into our mouths and lungs from a contaminated handrail or doorknob. To cut off these routes of indirect transmission, researchers at Miami University in Ohio are developing polymer coatings for public surfaces that have the potential to capture and inactivate SARS-CoV-2, the virus that causes COVID-19.

Page-Rick-400x461.jpg
Jeff Sabo/University of Miami Ohio
Rick Page

Rick Page and Dominik Konkolewicz, who specialize in protein biochemistry and polymer chemistry, respectively, recently received $181,849 from the National Science Foundation for this work. They plan to develop protein–polymer materials that can use peptides to either capture the virus by grabbing onto its spike proteins or inactivate the virus by disrupting its outer lipid layer, or do both.

Konkolewicz-Dominik-400x460.jpg
Jeff Sabo/University of Miami Ohio
Dominik Konkolewicz

“We're taking two reasonably different areas of chemistry and putting them together to make advances on both sides,” Page said. “Neither of us would be able to do this on our own."

Page and Konkolewicz have been collaborating for more than six years and have worked on applying functional groups that can disrupt vesicles and other lipid layers to polymer coatings. They investigate both how synthetic macromolecules behave in contact with biological species and how biological membranes interact with the polymers, as sticking macromolecules to a synthetic surface can cause changes in the combined 3-D net-like structure that affect the performance of both materials.

“We can change how closely we pack the net elements and where we place different groups,” Konkolewicz said. “If we change the structure in a systematic fashion, how does that impact the material's performance?”

The researchers also intend to evaluate the overall durability of the polymer–protein coatings once they’ve been applied to a surface; a coating that rubs off the first time someone touches it would be of little practical use.

“We can put the peptides (right) on surfaces … but there's very little chance that the peptide would stay on the surface for the length of time that we want it to. So if we're looking at a doorknob, and you touch the doorknob, the peptide's gone,” Konkolewicz said. "On the other extreme, we can make purely synthetic materials that have an incredibly long lifetime but don't have any biological function.”

According to Page, another challenge will be ensuring that functional groups remain active in the environment where the materials are tested.

“We typically think of them acting in water, but we're going to be putting them on a surface where they may very well be getting dried,” he said. “(We’re) trying to figure out how much of these we need to put on the surface and if we can keep the groups functional so they are still able to sequester a virion.”

Like researchers at most universities, Page and Konkolewicz have had their labs — which are around 1,400 square feet each — closed since mid-March. However, they recently received approval to begin working on their NSF-funded project in June, which will entail researchers working in shifts and maintaining appropriate distance from one another.

“I think it's going to start off with a few graduate students coming back,” Page said. “We’re doing all of the intro work that we can (for the COVID-19 project) at home … to try to get things ready to go so that come June 1, we can hit the ground running.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
John Arnst

John Arnst was a science writer for ASBMB Today.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

E-cigarettes drive irreversible lung damage via free radicals
Journal News

E-cigarettes drive irreversible lung damage via free radicals

April 17, 2025

E-cigarettes are often thought to be safer because they lack many of the carcinogens found in tobacco cigarettes. However, scientists recently found that exposure to e-cigarette vapor can cause severe, irreversible lung damage.

Using DNA barcodes to capture local biodiversity
ASBMB Annual Meeting

Using DNA barcodes to capture local biodiversity

April 15, 2025

Undergraduate at the University of California, Santa Barbara, leads citizen science initiative to engage the public in DNA barcoding to catalog local biodiversity, fostering community involvement in science.

Targeting Toxoplasma parasites and their protein accomplices
Journal News

Targeting Toxoplasma parasites and their protein accomplices

April 11, 2025

Researchers identify that a Toxoplasma gondii enzyme drives parasite's survival. Read more about this recent study from the Journal of Lipid Research.

Scavenger protein receptor aids the transport of lipoproteins
Journal News

Scavenger protein receptor aids the transport of lipoproteins

April 11, 2025

Scientists elucidated how two major splice variants of scavenger receptors affect cellular localization in endothelial cells. Read more about this recent study from the Journal of Lipid Research.

Fat cells are a culprit in osteoporosis
Journal News

Fat cells are a culprit in osteoporosis

April 11, 2025

Scientists reveal that lipid transfer from bone marrow adipocytes to osteoblasts impairs bone formation by downregulating osteogenic proteins and inducing ferroptosis. Read more about this recent study from the Journal of Lipid Research.

Unraveling oncogenesis: What makes cancer tick?
ASBMB Annual Meeting

Unraveling oncogenesis: What makes cancer tick?

April 7, 2025

Learn about the ASBMB 2025 symposium on oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer.